Successful management of immunotherapy-resistant respiratory failure in anti-mitochondrial M2 antibody-positive myositis by modified lung volume recruitment therapy: A case report
The mLVR therapy is an effective respiratory rehabilitation for patients with weakened respiratory muscles or tracheostomy. It allows the intensity of treatment to be adjusted based on the patient's symptoms, making it both highly effective and safe. This case suggests that mLVR therapy may be effective in treating severe, immunotherapy-resistant respiratory failure in AMA-positive myositis.
Authors
- Seiya Takahashi
- Daishi Watanabe
- Ryuta Kinno (ORCID: https://orcid.org/0000-0002-1905-2869)
- Sara Mori (ORCID: https://orcid.org/0009-0000-8339-2983)
- Akinori Futamura (ORCID: https://orcid.org/0000-0002-3485-5846)
- Kazuki Komaba
- Yoko Nabeshima
- Taro Yasumoto
- Hiroyasu Inoue (ORCID: https://orcid.org/0000-0003-3055-0057)
- Satoshi Nogawa
- Kaho Onizawa
- Takahiro Shinohara (ORCID: https://orcid.org/0009-0002-1331-2428)
- Hiroyasu Komuro
- Seiji Amano
- Rihito Mitsuhashi
Institutions
- SHOWA Medical University Fujigaoka Hospital (JP)
Publication Details
- Journal
- Medicine
- Published
- 2024-12-13
- DOI
- https://doi.org/10.1097/md.0000000000040912
- Citations
- 2
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.77
Funders
- Japan Society for the Promotion of Science